PDS Biotech Completes Enrollment of Lead-In Safety Cohort in VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer FLORHAM PARK, N.J., Sept. 09, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq:...
Kit Check Hires New Chief Technology Officer WASHINGTON, August 30 – Kit Check today announced the addition of Vijay Venkatesh as Chief Technology Officer. Mr. Venkatesh brings vast expertise leading technology teams that have used new data sets and business models to...
TigerConnect Announces Expanded Product Suite to Revolutionize Clinical Collaboration and Cut Care CostsIntuitive Communication Capabilities Designed Around and For Today’s Healthcare Worker SANTA MONICA, Calif. — August 5, 2021 — TigerConnect, healthcare’s most...
Rallybio Announces Clinical Proof of Concept for RLYB211, an Anti-HPA-1a Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) — Data to be Presented at the International Society on Thrombosis and Haemostasis (ISTH) 2021 Virtual...
Rallybio Corporation Announces Pricing of Initial Public Offering NEW HAVEN, Conn.–(BUSINESS WIRE)–Jul. 28, 2021– Rallybio Corporation (Rallybio), a clinical-stage biotechnology company committed to identifying and accelerating the development of...
Cleerly Launches with $43 Million Series B to Provide a New Standard of Care for the Leading Cause of Death – Heart Disease Resulting from More than a Decade of Clinical Research, Company Unveils Non-Invasive Approach to Identify, and New Care Pathways to Address...
Recent Comments